- Home
- SLQT vs AQST Comparison
SLQT vs AQST Comparison
Compare SLQT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- AQST
- Stock Information
- Founded
- SLQT 1999
- AQST 2004
- Country
- SLQT United States
- AQST United States
- Employees
- SLQT N/A
- AQST N/A
- Industry
- SLQT Specialty Insurers
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- AQST Health Care
- Exchange
- SLQT Nasdaq
- AQST Nasdaq
- Market Cap
- SLQT 343.7M
- AQST 390.4M
- IPO Year
- SLQT 2020
- AQST 2018
- Fundamental
- Price
- SLQT $1.93
- AQST $4.11
- Analyst Decision
- SLQT Hold
- AQST Strong Buy
- Analyst Count
- SLQT 2
- AQST 6
- Target Price
- SLQT $4.38
- AQST $10.67
- AVG Volume (30 Days)
- SLQT 1.2M
- AQST 1.2M
- Earning Date
- SLQT 08-21-2025
- AQST 08-11-2025
- Dividend Yield
- SLQT N/A
- AQST N/A
- EPS Growth
- SLQT N/A
- AQST N/A
- EPS
- SLQT N/A
- AQST N/A
- Revenue
- SLQT $1,488,701,000.00
- AQST $44,132,000.00
- Revenue This Year
- SLQT $17.27
- AQST N/A
- Revenue Next Year
- SLQT $13.23
- AQST $51.62
- P/E Ratio
- SLQT N/A
- AQST N/A
- Revenue Growth
- SLQT 20.41
- AQST N/A
- 52 Week Low
- SLQT $1.62
- AQST $2.12
- 52 Week High
- SLQT $6.86
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- SLQT 44.59
- AQST 58.49
- Support Level
- SLQT $1.90
- AQST $3.69
- Resistance Level
- SLQT $2.14
- AQST $4.24
- Average True Range (ATR)
- SLQT 0.13
- AQST 0.24
- MACD
- SLQT 0.03
- AQST -0.01
- Stochastic Oscillator
- SLQT 56.25
- AQST 72.41
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.